Fagron Compounding Services 2025-09-24 Health serious FDA
Health · FDA · Recall #FDA-D-0646-2025
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose… Recall
Issued September 24, 2025 · Fagron Compounding Services
In September 2025, Fagron Compounding Services recalled the bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Fagron Compounding Services to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Fagron Compounding Services
- Category
- Health
- Recall date
- September 24, 2025
- Units affected
- Not reported
- Sold at
- USA nationwide.
- Recall number
- FDA-D-0646-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Fagron Compounding Services has 5 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.